a member


Best Oral Abstract Award AEPC Working Group “Pulmonary Hypertension, Heart Failure and Transplantation” (PHHFTx)

Last updates Oct 5, 2019

The WG’s leadership board of the working group PHHFTx scores and selects 6 abstracts as “best oral abstracts” from all abstracts already accepted for presentation at AEPC 2020. These 6 abstracts will be presented at the best abstract session “PHHFTx” in Gothenburg, 2020.


Thus, all abstracts must be submitted through the official AEPC website, and indicate the categories pulmonary hypertension or heart failure/heart transplantation.


All such accepted abstracts will be scored again by the PHHFTx WG leadership board. The winner will be determined after the oral abstract presentations.


In 2020, the WG PHHFTx offers one best oral abstract award (2000 EUR).

The first and presenting author of the abstract must not be senior faculty (i.e., we will give an award only to graduate students, PostDocs, resident, fellow, or junior faculty).

“Junior faculty” is defined as an academic who is not or less than 5 years faculty.


Questions? Correspondence to:

Prof. Dr. Martin Koestenberger, Email:


Prof. Dr. Georg Hansmann; Email:



Criteria for high best oral abstract scores at AEPC Gothenburg 2020 are:

  1. well-conducted, hypothesis driven, basic-translational science studies that are meaningful for human disease and/or unravel

fundamentallly new pathobiological or therapeutic mechanisms

  1. prospective, hypothesis-driven clinical studies including a comparative group (as opposed to historical controls)
  2. large, well-conducted retrospective studies that yield conclusions that are useful for patient care
  3. large, patient registries that adress a relevant clincial question



Abstracts we do not score at all or do not give high scores, for the best oral abstract session (WG PHHFTX):

  1. case reports
  2. case series
  3. small retrospective studies
  4. retrospective studies that are entirely descriptive in nature and do not allow any clinically relevant conclusions.
  5. prospective studies that have errors in the study design and as such are not conclusive
  6. basic science or genetic studies that do not deal directly with "pulmonary hypertension", "heart failure", "ventricular dysfunction" or other strongly-related areas of research
  7. abstracts that have been presented in identical or similar form at AEPC congress or any other preceding international meeting
  8. abstracts that have been published or which include > 50% data that have been published
  9. abstracts that do not have a student, resident, fellow or junior faculty as presenter and first author.
  10. abstracts that contain published data to a significant extend
back to homepage